BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6298636)

  • 1. An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D.
    Weis JH; Enquist LW; Salstrom JS; Watson RJ
    Nature; 1983 Mar; 302(5903):72-4. PubMed ID: 6298636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological properties of an N-terminal fragment of herpes simplex virus type 1 glycoprotein D expressed in Escherichia coli.
    Kocken CH; Geerligs HJ; Bos CA; Ab G; Weijer WJ; Drijfhout JW; Welling GW; Welling-Wester S
    Arch Virol; 1988; 103(3-4):267-74. PubMed ID: 2850785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial synthesis of herpes simplex virus types 1 and 2 glycoprotein D antigens.
    Watson RJ; Weis JH; Salstrom JS; Enquist LW
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):102s-111s. PubMed ID: 6330215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.
    Dix RD; Mills J
    J Med Virol; 1985 Sep; 17(1):9-18. PubMed ID: 2995573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
    Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.
    Bröker M; Abel KJ; Köhler R; Hilfenhaus J; Amann E
    Med Microbiol Immunol; 1990; 179(3):145-59. PubMed ID: 2169577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relatedness of glycoproteins expressed on the surface of simian herpes-virus virions and infected cells to specific HSV glycoproteins.
    Eberle R; Black D; Hilliard JK
    Arch Virol; 1989; 109(3-4):233-52. PubMed ID: 2482016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Herpes simplex virus type 1 glycoprotein C antigens in Escherichia coli.
    Amann E; Bröker M; Wurm F
    Gene; 1984 Dec; 32(1-2):203-15. PubMed ID: 6099309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J; Szczesiul MS; Marlin SD; Levine M
    Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells.
    Ligas MW; Johnson DC
    J Virol; 1988 May; 62(5):1486-94. PubMed ID: 2833603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge.
    Eisenberg RJ; Cerini CP; Heilman CJ; Joseph AD; Dietzschold B; Golub E; Long D; Ponce de Leon M; Cohen GH
    J Virol; 1985 Dec; 56(3):1014-7. PubMed ID: 2999419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.
    Cohen GH; Dietzschold B; Ponce de Leon M; Long D; Golub E; Varrichio A; Pereira L; Eisenberg RJ
    J Virol; 1984 Jan; 49(1):102-8. PubMed ID: 6197535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro.
    Weijer WJ; Drijfhout JW; Geerligs HJ; Bloemhoff W; Feijlbrief M; Bos CA; Hoogerhout P; Kerling KE; Popken-Boer T; Slopsema K
    J Virol; 1988 Feb; 62(2):501-10. PubMed ID: 2826811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.
    Geerligs HJ; Kocken CH; Drijfhout JW; Weijer WJ; Bloemhoff W; Wilterdink JB; Welling GW; Welling-Wester S
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1767-74. PubMed ID: 2167930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression in bacteria of gB-glycoprotein-coding sequences of Herpes simplex virus type 2.
    Person S; Warner SC; Bzik DJ; Debroy C; Fox BA
    Gene; 1985; 35(3):279-87. PubMed ID: 2412940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid procedure for the enrichment of undenaturated, antigenically active herpes simplex virus glycoproteins.
    Respess RA; Pancake BA; Edson CM; Schaffer PA
    J Virol Methods; 1984 Feb; 8(1-2):27-45. PubMed ID: 6200489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.
    Pereira L; Dondero D; Norrild B; Roizman B
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5202-6. PubMed ID: 6272294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.